As Loral Space & Communicatns I (LORL) Share Value Declined, Altalis Capital Management Lifted Position; Peapack Gladstone Financial Has Boosted Stake in Gilead Sciences (GILD) by $207.54 Million

May 21, 2018 - By Richard Conner

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Peapack Gladstone Financial Corp increased its stake in Gilead Sciences Inc (GILD) by 43.89% based on its latest 2017Q4 regulatory filing with the SEC. Peapack Gladstone Financial Corp bought 2,897 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 9,498 shares of the health care company at the end of 2017Q4, valued at $680.44 million, up from 6,601 at the end of the previous reported quarter. Peapack Gladstone Financial Corp who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $88.55B market cap company. The stock increased 0.12% or $0.08 during the last trading session, reaching $68.1. About 1.48M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 21, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Adam Fox increased its stake in Loral Space & Communicatns I (LORL) by 40.8% based on its latest 2017Q4 regulatory filing with the SEC. Altalis Capital Management Llc bought 35,141 shares as the company’s stock declined 4.19% with the market. The hedge fund run by Adam Fox held 121,261 shares of the technology company at the end of 2017Q4, valued at $5.34M, up from 86,120 at the end of the previous reported quarter. Altalis Capital Management Llc who had been investing in Loral Space & Communicatns I for a number of months, seems to be bullish on the $1.22 billion market cap company. The stock increased 0.13% or $0.05 during the last trading session, reaching $39.45. About 5,050 shares traded. Loral Space & Communications Inc. (NASDAQ:LORL) has risen 7.35% since May 21, 2017 and is uptrending. It has underperformed by 4.20% the S&P500.

More recent Loral Space & Communications Inc. (NASDAQ:LORL) news were published by: Seekingalpha.com which released: “Loral Space & Communications’ (LORL) CEO Dan Goldberg on Q1 2018 Results – Earnings Call Transcript” on May 06, 2018. Also Streetinsider.com published the news titled: “Omega’s 13F Shows Increase in Ocwen (OCN), Synchrony (SYF), United (UAL), Exits Zynga (ZNGA) (More…)” on May 15, 2018. Nasdaq.com‘s news article titled: “Telesat Reports Results for the Quarter Ended March 31, 2018” with publication date: May 03, 2018 was also an interesting one.

Altalis Capital Management Llc, which manages about $283.10M and $102.64M US Long portfolio, decreased its stake in Magellan Health Inc (NASDAQ:MGLN) by 41,653 shares to 88,853 shares, valued at $8.58 million in 2017Q4, according to the filing. It also reduced its holding in Calpine Corp (NYSE:CPN) by 162,134 shares in the quarter, leaving it with 52,392 shares, and cut its stake in News Corp New (NASDAQ:NWS).

Investors sentiment decreased to 1 in Q4 2017. Its down 0.68, from 1.68 in 2017Q3. It turned negative, as 2 investors sold LORL shares while 34 reduced holdings. 8 funds opened positions while 28 raised stakes. 20.80 million shares or 0.69% more from 20.65 million shares in 2017Q3 were reported. United Kingdom-based Barclays Plc has invested 0% in Loral Space & Communications Inc. (NASDAQ:LORL). 28,657 were accumulated by Millennium Mngmt Ltd Limited Liability Company. Moreover, Gamco Et Al has 0.2% invested in Loral Space & Communications Inc. (NASDAQ:LORL). Horizon Kinetics Lc holds 17,920 shares or 0.02% of its portfolio. Moreover, Levin Cap Strategies LP has 0% invested in Loral Space & Communications Inc. (NASDAQ:LORL) for 6,000 shares. State Street Corporation holds 283,019 shares or 0% of its portfolio. Schwab Charles Investment Mngmt reported 57,049 shares stake. Northern Tru Corp stated it has 0% of its portfolio in Loral Space & Communications Inc. (NASDAQ:LORL). Bnp Paribas Arbitrage Sa stated it has 0% in Loral Space & Communications Inc. (NASDAQ:LORL). Bank Of Mellon Corporation accumulated 105,238 shares or 0% of the stock. Highland Capital Management LP has 2.06M shares for 4.17% of their portfolio. Nokomis Limited Liability Co holds 3.31% of its portfolio in Loral Space & Communications Inc. (NASDAQ:LORL) for 331,723 shares. Parallax Volatility Advisers Lp owns 3,207 shares. Hawk Ridge Capital Management Ltd Partnership reported 151,327 shares or 2.22% of all its holdings. Aperio Gp Ltd Liability owns 16,058 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. As per Monday, February 12, the company rating was maintained by Mizuho. Jefferies maintained the shares of GILD in report on Wednesday, October 4 with “Hold” rating. Needham maintained the shares of GILD in report on Wednesday, July 29 with “Buy” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Monday, October 3 report. The company was downgraded on Wednesday, December 20 by Credit Suisse. The firm earned “Buy” rating on Thursday, September 22 by Berenberg. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Outperform” rating given on Wednesday, February 3 by Oppenheimer. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Neutral” rating given on Wednesday, February 8 by Citigroup. The rating was maintained by Oppenheimer with “Hold” on Thursday, December 21. The firm has “Buy” rating by Mizuho given on Tuesday, July 25.

Peapack Gladstone Financial Corp, which manages about $1862.93B US Long portfolio, decreased its stake in Charles Schwab Corp (NYSE:SCHW) by 275 shares to 378,713 shares, valued at $19.45B in 2017Q4, according to the filing. It also reduced its holding in Kraft Heinz Co by 1,811 shares in the quarter, leaving it with 12,407 shares, and cut its stake in Avery Dennison Corp (NYSE:AVY).

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead: I’m Thankful That I Sold” on May 07, 2018, also Seekingalpha.com with their article: “Gilead Sciences: Resist Sentiment, Stop Speculating And Invest” published on May 15, 2018, Seekingalpha.com published: “AbbVie’s Mavyret Could Punish Gilead Tuesday” on April 30, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: What A Disaster” published on May 08, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead Sciences (GILD) Presents at Bank of America Merrill Lynch 2018 Healthcare Conference (Transcript)” with publication date: May 16, 2018.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>